Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research ...

UCB has shared promising results from a late-stage study of fenfluramine in patients with an ultra-rare form of epilepsy. The ...

Crouch most recently served as therapeutic lead, oncology and specialty medicine for international developed markets at ...

With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience ...

Using technology to make your exhibitions stand out in 2025. In today’s fast-paced experience economy, pharma companies can ...